Not medical advice. Talk to your provider before using any peptide. Full disclaimer
Peptide Schedule Research TeamReviewed Apr 7, 20266 Citations
Danuglipron Dosage Calculator
Weight Loss · Research · Grade C · ~6-8 hours half-life · Oral
Danuglipron Dosage
| Level | Dose | Frequency |
|---|---|---|
| Beginner | 10 mg | 2x Daily |
| Moderate | 80 mg | 2x Daily |
| Aggressive | 120 mg | 2x Daily |
Cycle: No scheduled off period.
No syringe calculation for this route
Oral
Danuglipron has no default water volume for this calculator, so there are no syringe units to calculate here. Dosing runs 10 mg to 120 mg per administration, 2x daily.
If your product does arrive as a powder, use the universal reconstitution calculator and enter your own vial size and water volume.
About Danuglipron
Beginner, moderate, and aggressive dosing amounts with timing. Free to use.
Danuglipron was Pfizer's oral small-molecule GLP-1 agonist. Phase 2b trials showed 5 to 13 percent weight loss at 32 weeks, but severe GI side effects caused over 50 percent dropout. Development stopped in April 2025 after a drug-induced liver injury signal.
View side effects and safety warnings →
Quick-Start: How to Use Danuglipron
- 1Danuglipron was studied as an oral tablet taken twice daily, approximately 12 hours apart.
- 2Starting dose in the obesity trial was 40 mg BID. T2D trials started as low as 2.5 mg BID.
- 3Take with or without food. Pharmacokinetic data confirmed similar plasma exposure in fed and fasted states.
Danuglipron Dosing Protocol
| Level | Dose | Frequency |
|---|---|---|
| Beginner | 10 mg | 2x Daily |
| Moderate | 80 mg | 2x Daily |
| Aggressive | 120 mg | 2x Daily |
Danuglipron is an oral tablet. No vials, no reconstitution, no bacteriostatic water. That's the entire practical appeal and why Pfizer invested in this program.
The twice-daily dosing schedule matters. The half-life is roughly 6 to 8 hours, so missing a dose creates a 12 to 16 hour gap in receptor coverage. If you're reading about this compound for research context, the clinical doses ranged from 2.5 mg BID up to 200 mg BID depending on the trial and arm. The obesity trial targeted 40 to 200 mg BID. The T2D trial tested 2.5, 10, 40, 80, and 120 mg BID.
Slow titration is the only tolerability strategy that showed any benefit. The 4-week titration schedule in Cohort 3 of the obesity trial [1] produced the best efficacy data (32 weeks at target dose) and better completion rates than faster titration arms.
This drug is not available from compounding pharmacies. No FDA-approved reference drug exists, which means 503A and 503B pharmacies cannot legally compound it. It is sold only as a lab reagent for research; those products are explicitly not for human consumption.
Dosing based on Phase 2b trial: danuglipron (PF-06882961) in adults with type 2 diabetes (Saxena et al., JAMA Netw Open 2023): 6 published references.View all sources →
Ask AI about this math
Cross-check your Danuglipron reconstitution math with AI
Danuglipron Cost
Prices are estimates and vary by source, location, and prescription status.Full pricing breakdown →
Danuglipron Pharmacokinetics
Pharmacokinetics: Active Dose Over Time
t½ = ~6-8 hoursDisclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only, not medical advice.
Related Tools
Frequently Asked Questions
How popular is Danuglipron?
Niche. A popularity tier (hot, popular, emerging or niche), based on search volume and community activity.
Reddit: 20. Community mentions on Reddit: <20 threads: Pfizer discontinued development.
45 papers on PubMed, the US library of medical research. Search them on PubMed (opens in a new tab).
Low search interest. A band for how often people search Google for the name each month.
These come from this site's peptide records. They are not live counts.